Abstract Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
AbstractList Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Author MOTTER, CHRISTOPHER E
CASPI, DANIEL D
TUFANO, MICHAEL D
WAGAW, SEBLE H
HUTCHINS, CHARLES W
LI, WENKE
RANDOLPH, JOHN T
PATEL, SACHIN V
PRATT, JOHN K
HUTCHINSON, DOUGLAS K
LIU, DACHUN
KRUEGER, ALLAN C
KATI, WARREN M
WAGNER, CHARLES A
NELSON, LISSA T
BETEBENNER, DAVID A
FLENTGE, CHARLES A
YI, GAO
SARRIS, KATHY
BELLIZZI, MARY E
MATULENKO, MARK A
CALIFANO, JEAN C
WOLLER, KEVIN R
KEDDY, RYAN G
ROCKWAY, TODD W
MARING, CLARENCE J
DEGOEY, DAVID A
DONNER, PAMELA L
JINKERSON, TAMMIE K
Author_xml – fullname: PATEL, SACHIN V
– fullname: KEDDY, RYAN G
– fullname: HUTCHINS, CHARLES W
– fullname: LIU, DACHUN
– fullname: DONNER, PAMELA L
– fullname: RANDOLPH, JOHN T
– fullname: ROCKWAY, TODD W
– fullname: KATI, WARREN M
– fullname: TUFANO, MICHAEL D
– fullname: HUTCHINSON, DOUGLAS K
– fullname: KRUEGER, ALLAN C
– fullname: FLENTGE, CHARLES A
– fullname: BETEBENNER, DAVID A
– fullname: BELLIZZI, MARY E
– fullname: YI, GAO
– fullname: JINKERSON, TAMMIE K
– fullname: SARRIS, KATHY
– fullname: MARING, CLARENCE J
– fullname: WAGAW, SEBLE H
– fullname: LI, WENKE
– fullname: DEGOEY, DAVID A
– fullname: CALIFANO, JEAN C
– fullname: CASPI, DANIEL D
– fullname: WOLLER, KEVIN R
– fullname: WAGNER, CHARLES A
– fullname: NELSON, LISSA T
– fullname: PRATT, JOHN K
– fullname: MOTTER, CHRISTOPHER E
– fullname: MATULENKO, MARK A
BookMark eNrjYmDJy89L5WSQ8UgtSCzJLMksVnBWKMssKi1WyMzLyEzKLMkvKuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAUbGZhYWlgZOhsZEKAEALjclNQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Hepatitis C Virus Inhibitoren
Inhibiteurs de la hépatite C
ExternalDocumentID EP2368890B1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2368890B13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:59:17 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2368890B13
Notes Application Number: EP20110160830
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130417&DB=EPODOC&CC=EP&NR=2368890B1
ParticipantIDs epo_espacenet_EP2368890B1
PublicationCentury 2000
PublicationDate 20130417
PublicationDateYYYYMMDD 2013-04-17
PublicationDate_xml – month: 04
  year: 2013
  text: 20130417
  day: 17
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies ABBVIE BAHAMAS LIMITED
RelatedCompanies_xml – name: ABBVIE BAHAMAS LIMITED
Score 2.8864448
Snippet Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Hepatitis C virus inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130417&DB=EPODOC&locale=&CC=EP&NR=2368890B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-J0Sh-kb8Wtq0nzUISmLUXYVmTK3kbTZpiXOtZO_30voZu-6NuRwOUD7uN3yd0B3OceHZakIA5lZa6jVa6TE8YQ8zBfipKhhdZAcTIl6av3vHhcdEDtcmFMndAvUxwRJapAeW-Mvl7_BLEi87eyfhAKhz6eknkQ2S06RoXsjagdhUGczaIZtzlHyp6-BO6Y-D4bhgiUDtCLploY4rdQJ6Wsf1uU5BQOM2RWNWfQkVUPjvmu8VoPjibtezeSrejV5zBIpf783Kja4tan2mxrS1XvSijdLucCrCSe89TBZZb7Iy3jbL-h8SV0EenLK7CExh_SJfnI9z23oALBAStW3qrI0e0qaR_6f7K5_mfuBk5c08XBc0Z0AN1ms5W3aEsbcWdu4RvAN3dL
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjVWq3Iw3IiFIsseiAmvoBZKDJreCI9t3As2herfd5bQ6kVvk91k9pHM45vdmQG4zXQyKY3CUAgtMxGt0pTMoBQxDzVZXlK00AIohpERvOpPi_tFD_g2F6atE_rVFkdEiSpQ3ptWX69-glhu-7eyvss5Dn08-Inlyh06RoWsq0R2bcuL5-7ckR0HKTl6sbSpYZp0YiNQ2kMPmwhh8N5skZSy-m1R_CPYj5FZ1RxDj1VDGDjbxmtDOAi7924kO9GrT2AcMPH5ueG15EiffL2pJV6985yLdjmnIPle4gQKLpPujpR68W5D0zPoI9Jn5yDlAn8wzchU09S1guQIDmix1JdFhm5XSUYw-pPNxT9zNzAIknCWzh6j50s41NqODrqikjH0m_WGXaFdbfLr9ka-AYLBej4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Hepatitis+C+virus+inhibitors&rft.inventor=PATEL%2C+SACHIN+V&rft.inventor=KEDDY%2C+RYAN+G&rft.inventor=HUTCHINS%2C+CHARLES+W&rft.inventor=LIU%2C+DACHUN&rft.inventor=DONNER%2C+PAMELA+L&rft.inventor=RANDOLPH%2C+JOHN+T&rft.inventor=ROCKWAY%2C+TODD+W&rft.inventor=KATI%2C+WARREN+M&rft.inventor=TUFANO%2C+MICHAEL+D&rft.inventor=HUTCHINSON%2C+DOUGLAS+K&rft.inventor=KRUEGER%2C+ALLAN+C&rft.inventor=FLENTGE%2C+CHARLES+A&rft.inventor=BETEBENNER%2C+DAVID+A&rft.inventor=BELLIZZI%2C+MARY+E&rft.inventor=YI%2C+GAO&rft.inventor=JINKERSON%2C+TAMMIE+K&rft.inventor=SARRIS%2C+KATHY&rft.inventor=MARING%2C+CLARENCE+J&rft.inventor=WAGAW%2C+SEBLE+H&rft.inventor=LI%2C+WENKE&rft.inventor=DEGOEY%2C+DAVID+A&rft.inventor=CALIFANO%2C+JEAN+C&rft.inventor=CASPI%2C+DANIEL+D&rft.inventor=WOLLER%2C+KEVIN+R&rft.inventor=WAGNER%2C+CHARLES+A&rft.inventor=NELSON%2C+LISSA+T&rft.inventor=PRATT%2C+JOHN+K&rft.inventor=MOTTER%2C+CHRISTOPHER+E&rft.inventor=MATULENKO%2C+MARK+A&rft.date=2013-04-17&rft.externalDBID=B1&rft.externalDocID=EP2368890B1